Luoxin Pharmaceutical (002793)
SZSE · 002793
Record TypeProfile record
Record UpdatedJun 4, 2026
Market Cap$4.5B
Revenue$2.4B
Employees2962
Listed OnSZSE
Ticker002793
CEO / ExecMr. Zhenteng Liu
HeadquartersLinyi
MarketMainland China
Websitewww.luoxin.cn
Overview
Luoxin Pharmaceuticals Group Stock Co., Ltd. engages in the research and development, manufacture, and trading of drugs in China. The company provides antiviral, anti-infective, respiratory and digestive system, nervous and endocrine system, cardiovascular system, oncology, and anti-allergic APIs and intermediates, as well as antipyretic, analgesics, and anti-inflammatory APIs and intermediates. It also offers health care services. Luoxin Pharmaceuticals Group Stock Co., Ltd. was formerly known
Source Note
This record combines exchange fields with selected profile enrichment. Treat market data, leadership and financial figures as directional unless verified against company filings, exchange announcements or the issuer's own disclosures.